Flavia Borellini
Director/Board Member bij REVOLUTION MEDICINES, INC.
Vermogen: 323 009 $ op 31-03-2024
Actieve functies van Flavia Borellini
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REVOLUTION MEDICINES, INC. | Director/Board Member | 22-06-2021 | - |
| Independent Dir/Board Member | 22-06-2021 | - | |
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 14-08-2021 | - |
| Independent Dir/Board Member | 14-08-2021 | - | |
| CANTARGIA AB | Director/Board Member | 01-10-2020 | - |
| Independent Dir/Board Member | 01-10-2020 | - | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Director/Board Member | 01-02-2018 | - |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Loopbaan van Flavia Borellini
Eerdere bekende functies van Flavia Borellini
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-09-2018 | 01-01-2020 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Chief Executive Officer | 01-02-2016 | 01-02-2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-10-2012 | 01-10-2013 |
Opleiding van Flavia Borellini
| Università degli Studi di Modena e Reggio Emilia | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
| Zwitserland | 2 |
Operationeel
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
Sectoraal
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CANTARGIA AB | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
- Beurs
- Insiders
- Flavia Borellini
- Ervaring
